HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chiara Bongiovanni Selected Research

Neoplasms (Cancer)

3/2022NRG1/ERBB3/ERBB2 Axis Triggers Anchorage-Independent Growth of Basal-like/Triple-Negative Breast Cancer Cells.
1/2022Neuregulin 4 Boosts the Efficacy of Anti-ERBB2 Neutralizing Antibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chiara Bongiovanni Research Topics

Disease

2Neoplasms (Cancer)
03/2022 - 01/2022
2Breast Neoplasms (Breast Cancer)
03/2022 - 01/2022
1Triple Negative Breast Neoplasms
03/2022
1Cardiotoxicity
01/2022
1Heart Failure
01/2022

Drug/Important Bio-Agent (IBA)

2Messenger RNA (mRNA)IBA
03/2022 - 01/2022
1Neuregulin-1 (Neuregulin 1)IBA
03/2022
1Neutralizing AntibodiesIBA
03/2022
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2022
1NeuregulinsIBA
01/2022
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022
1Antineoplastic Agents (Antineoplastics)IBA
01/2022
1LigandsIBA
01/2022
1Phenobarbital (Luminal)FDA Link
01/2022
1SuspensionsIBA
01/2022

Therapy/Procedure

1Therapeutics
01/2022
1Drug Therapy (Chemotherapy)
01/2022